What is Walnut?
Walnut is a fintech company that addresses the critical need for financial accessibility in healthcare. It has developed a point-of-sale embedded lending platform designed to break down large medical bills into manageable monthly payments. This solution not only empowers patients to afford necessary medical care but also enhances revenue capture and collection rates for healthcare providers, thereby improving the financial health of the entire healthcare ecosystem.
How much funding has Walnut raised?
Walnut has raised a total of $110M across 1 funding round:
Series A
$110M
Series A (2022): $110M with participation from Clear Haven Capital Management and Gradient Ventures
Key Investors in Walnut
Clear Haven Capital Management
Clear Haven Capital Management is an investment advisor specializing in identifying high-potential cash flow streams, offering a full lifecycle asset-backed credit platform for various clients. They focus on creating sustainable value through tailored financial solutions.
Gradient Ventures
Gradient Ventures is a San Francisco-based climatetech manufacturer focused on producing high-efficiency HVAC units. Their investment in Walnut suggests an interest in innovative solutions that improve accessibility and efficiency, potentially extending beyond their core climatetech focus.
What's next for Walnut?
With the recent infusion of major strategic investment, Walnut is poised for significant scaling and further development of its embedded lending platform. This substantial backing, part of its $110M in total capital, suggests a strategic focus on expanding its market reach within the healthcare fintech sector. The company is likely to enhance its technological infrastructure, forge new partnerships with healthcare providers, and potentially explore additional financial products to solidify its position as a leader in making healthcare financially accessible.
See full Walnut company page
